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ABSTRACT
This study was undertaken to evaluate the magnitude of physiologic
changes which are known to occur in human subjects exposed to varying
levels of +G acceleration following bed rest simulation of weightlessness.
z
Bed rest effects were documented by fluid and electrolyte balance studies,
maximal exercise capability, 70° passive tilt and lower body negative
pressure tests and the ability to endure randomly prescribed acceleration
profiles of +2G , +3G , and +4G . Six healthy male volunteers were studied
z z z
during two weeks of bed rest after adequate control observations, followed
by two weeks of recovery, followed by a second two-week period of bed
rest at which time an Air Force cutaway anti-G suit was used to determine
its effectiveness as a countermeasure for observed cardiovascular changes
during acceleration. Results showed uniform and significant changes in
all measured parameters as a consequence of bed rest including a reduced
ability to tolerate +G acceleration. The use of anti-G suits significantly
Z
improved subject tolerance to all G exposures and returned measured para-
meters such as heart rate and blood pressure towards or to pre-bed-rest
(control) values in four of the six cases.
VI
A. Introduction
Design limitations existent in the planning of the space shuttle
vehicle may be such that crew and passengers will be exposed to head-
ward acting (+G ) acceleration stresses of 2 to 4 G for periods of up
z
to about 700 seconds. These periods of stress would occur following
periods of weightlessness, i.e., exposure to a "zero" gravitational
state, of various durations. Previous studies in this laboratory and
elsewhere utilizing bedrest as an analog of weightlessness, have docu-
mented changes in body fluid compartments and deterioration in exercise
(1 > 2)
capabilities. ' These studies have also demonstrated that ortho-
static hypotension and even syncope may occur upon 70° passive tilting
(equivalent to a + 1 GZ stress) following periods of simulated weight-
lessness, suggesting that post-bedrest exposure to even higher accel-
eration stresses would exaggerate the undesirable orthostatic responses.
Therefore, the present study was undertaken to evaluate the magnitude
of the physiologic changes which would occur in humans exposed to +2.1 G ,z
+3.2 G , and +3.8 G stresses achieved in the human centrifuge following
z z *
bedrest simulations of weightlessness. A leading hypothesis explains
the observed decrease in orthostatic tolerance following weightlessness
to pooling of blood and extracellular fluid in the extremities and pelvis
in the presence of already diminished plasma and extracellular fluid
volumes. For this reason, the modifying effect of an inflated standard
Air Force cutaway G-suit on physiologic responses to these +G stresses
Z
was evaluated.
B. Experimental Design
1. General
Healthy male volunteers, ages 24-27 years, served as subjects for
this study. All volunteers were recruited from the Federal Correctional
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Institution, Lompoc, California, by permission of the U.S. Bureau of
Prisons. They were screened initially by the Medical Staff of F.C.I.-
Lompoc to exclude major or chronic health defects, and potential volun-
teers were subjected to a 70° passive tilt for twenty minutes to exclude
the presence of autonomic insufficiency. A tilt table with English
saddle was provided to the F.C.I, staff for this purpose.
On completion of the screening procedure, the volunteers were trans-
ported to the U.S. Public Health Service Hospital, San Francisco, California,
and admitted to the Metabolic Unit. A complete medical history was ob-
tained and a complete physical examination was performed. The following
laboratory tests were done and were normal: 12 lead electrocardiogram,
PA and lateral chest x-rays, complete blood counts, serum sodium,
potassium, CC^ , chloride, phosphate, calcium, total protein, albumin,
globulin, alkaline phophatase, bilirubin, glutaaic-oxalacetic-
transaminase (GOT), creatinine, fasting blood glucose, blood urea
nitrogen, VDRL, and complete urinalysis with microscopic examination.
The details of the study were explained to each subject verbally
and in writing, and each subject signed an informed consent form.
Each volunteer was prescribed a specific metabolic diet throughout
the study. The dietetic aspects of the study are covered in the detailed
protocol. Eight to nine days on this diet were allowed for an equili-
bration period. During this time the volunteers were instructed in
urine collection and in intake recording by the metabolic nurses.
The study consisted of five phases .(which followed the 8-9 day
diet equilibration period): a 14 day ambulatory period (A 1-14); a
15 day bedrest period (B 1-15); a 14 day recovery period (R 1-14); a
second 15 day bedrest period (B'l-15); and a second 14 day recovery
period (R'l-14). During the ambulatory phases the environmental
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temperatures were maintained as nearly constant as possible, and no
exercise except normal walking was permitted in an attempt to avoid
large differences in insensible salt and water losses between the
ambulatory and bedrest phases. While at bedrest, the horizontal
position was required at all times with unrestricted movement in
this plane. Arm movement was limited to forearm raising with elbows
on the bed, and one pillow was permitted for head support. All oral
consumption and all excretory activities were performed in this
position. Excessive boredom was avoided by the use of radio,
television, reading material, and games.
2. Detailed Protocol
a. Daily Procedures
1) Temperature, pulse, and blood pressure measurement
once daily.
2) Determination of body weight on a metabolic balance
immediately after completion of 7:30 AM urine collection.
3) Determination of oral fluid intake and urine output.
b. Urine Collection and Analysis
1) Twenty-four hour collections were made daily. Each
voided sample was placed in a gallon container without
preservative. The urinal was rinsed with 50 ml of
distilled water which was also poured into the container.
The sum of the rinsing volume was deducted from the total
24 hour volume to determine urine output. Total volume
was utilized in calculating chemical data. All urines
were refrigerated until sample aliquots were obtained,
and the aliquots were frozen. Some daily aliquots were
kept separate where necessary to show acute changes,
and others were pooled. Pooling of the 5-7 day samples
was accomplished by combining 10% volume aliquots of
each sample into a single sample.
2) Urine Specimens Analysis
All samples were analyzed for Na, K, and creatinine.
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c. Blood Chemistries and Hematology
Blood samples were drawn on Days A3, A9, B2, B13(or 14),
R9, .B'2, B'14, R'12(or 13).
These were analyzed for Na , K , and hematocrit.
d. Isotopic Volume Studies
125
Plasma volume was determined by I-RISA, extracellular
82 51
fluid volume by Br, red cell mass by Cr, and total
3body water by 1^0 on the same days as the drawing of
blood samples listed above.
e. Tilt Studies
70° tilt studies were performed on Subjects 1 and 2 on
Days A13, B15, R13, and B'15. Tilt studies were not
performed on Subjects 3,4,5 and 6 who were subjected,
instead, to lower body negative pressure (LBNP) studies
(vide infra).
f. Lower Body Negative Pressure (LBNP) Studies
These studies were performed on Subjects 3,4,5 and 6
on Days A13, B15, R13, B'15, and R'14.
g. Exercise Studies
These studies were performed on Subjects 1 and 2 on
Days A13, B15, R13 and B'15 following recovery from the
tilt studies; and on Subjects 3,4,5 and 6 on Days A13,
B15, R13, B'15, R'14 following recovery from LBNP studies.
h. Centrifuge Studies
In all subjects, three training runs were performed in
the nine diet equilibration days before the start of the
first ambulatory period, and formal (data) studies were
performed on Days A14, Rl, R14, and R'l, i.e., 24 hours
following the tilt or LBNP and exercise studies.
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i. Metabolic Dietetic Program
All subjects were on a specific diet for the 8-9 day diet
equilibration period and throughout the entire study. Each subject
selected a menu of his own choice consisting of three meals and an
evening snack. The research dietician then calculated the nutrient
content of the chosen menu. Distilled water intake was allowed
ad lib, and a record of the volume consumed was recorded. The diet
was well-balanced, designed to maintain the subjects' body weight,
and the subjects ate all of the prescribed diet.
When particular diets were calculated to be inadequate
in vitamins, supplementation was given. Specific diet details are
elaborated below.
Subjects 1 and 2:
These subjects were fed a formula diet, prepared in the hospital's
main kitchen, with caloric values calculated to maintain body weight.
Each day the caloric intake and protein, fat, carbohydrate, sodium
and potassium contents of food consumed that day were calculated
from food content tables. The ranges of specific daily values are
listed below:
Diet Subject 1 Subject 2
Calories 2674 - 2983 2704 - 3066
Protein, grams 101.1 - 114.4 98.2 - 115.4
Fat, grams 130.3 - 157.0 129.4 - 140.4
Carbohydrate, grams 243.4 - 308.6 260.8 - 314.0
Sodium, milliequivalents 160.4 157.0
Potassium, milliequivalents 88.0 98«2
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Sublects 3 and 4:
These subjects consumed a semi-metabolic balance diet using
Armour frozen dinners for entrees. Most foods other than the frozen
dinners were weighed, but a few foods (e.g., milk, bread, eggs) were
not weighed. Two daily menus were used in rotation for each subject,
the menus of each subject being slightly different (Tables A and B).
The nutrient compositions of the diets for Subjects 3 and 4 shown in
Table C were calculated from food content tables and from data
furnished by Armour Laboratories. These calculated values were used
as the daily intake in the calculation of sodium and potassium
balances. .
Subjects 5 and 6:
These subjects consumed a metabolic balance diet with three
rotating menus:
v
Menu # 1 - served on Mondays, Wednesdays and Fridays
Menu # 2 - served on Tuesdays and Saturdays
Menu # 3 - served on Thursdays and Sundays.
The menus were the same for both subjects, and calories and
sodium were calculated to be about the same on all three menus
(Table D). Aliquots of the diet were analyzed for sodium and
potassium on Days A5, A9, AID, B13, B14, B15, B'l, B'2, B'3, B'13,
B'14, B'15; i.e., four aliquots of each of the three diets were
analyzed during the study. The results of these analyses and a
comparison with the calculated values are shown in Table E. The
calculated and analyzed values agree quite well. The average
analyzed values for the particular diet (1,2 or 3) consumed on
any given day were used to calculate sodium and potassium balances.
Breakfast
Lunch
Dinner
Snack
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TABLE A
MENUS FOR SUBJECT 3
Menu # 54
Orange juice
Cornflakes
Fried eggs (2)
White toast (2 si.)
Butter
Jelly
Whole milk
Sugar
Pepper
,u
Pot Roast Beef Dinner
(Rice, carrots, gravy)
Lettuce
Tomato
French dressing
White bread (1 si.)
Butter
Applesauce
Graham crackers (2)
Whole milk
Instant tea
Sugar
Pepper
Baked Chicken Dinner
(Baked pot., Green beans
with mushrooms)
Lettuce
Mayonnaise
White bread (1 si.)
Butter''
Dropped cookie (1)
Whole milk
Instant tea
Sugar
Pepper
Instant coffee
Canned pears
Menu #56
Pineapple juice
Oatmeal
Fried eggs (2)
White toast (2 si.)
Butter
Jelly
Whole milk
Sugar
Pepper
*
Veal Patty Dinner
(Sweet potatoes, peas)
Lettuce
French dressing
White bread (1 si.)
Butter
Vanilla wafers (4)
Whole milk
Instant tea
Sugar
Pepper
Filet Mignon Dinner
(Baked pot., Green beans
with mushrooms)
Lettuce
Tomato
Mayonnaise
White bread (1 si.)
Vanilla ice cream
Whole milk
Instant tea
Sugar
Pepper
Instant coffee
Canned peaches
2.0 grams NaCl for the day 2.6 grams NaCl for the day
Armour Frozen Dinners (Hospital Fare - Modified Diet)
Breakfast
Lunch
Dinner
Snack
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TABLE B
MENUS FOR SUBJECT 4
Menu # 53
Orange juice
Cornflakes
Poached eggs (2)
Whole wheat toast (2 si.)
Butter
Jelly
Whole milk
Sugar
Pepper
*
Pot Roast Beef Dinner
(Rice, carrots, gravy)
Lettuce
Tomato
French dressing
Whole wheat bread (1 si.)
Butter
Applesauce
Whole milk
Instant coffee
Sugar
Pepper
*
Baked Chicken Dinner
(Baked pot., Green beans
with mushrooms)
Lettuce
Mayonnaise
Whole wheat bread (1 si.)
Butter
Whole milk
Pepper
Instant coffee
Sugar
Canned pears
Menu #55
Pineapple juice
Oatmeal
Poached eggs (2)
Whole wheat toast (2 si.)
Butter
Jelly
Whole milk
Sugar
Pepper
*
Veal Patty Dinner
(Sweet potatoes, peas)
Lettuce
French dressing
Whole wheat bread (1 si.)
Butter
Vanilla wafers (2)
Whole milk
Instant coffee
Sugar
Pepper
Filet Mignon Dinner
(Baked pot., Green beans
with mushrooms)
Lettuce
Tomato
Mayonnaise
Whole wheat bread (1 si.)
Butter
Vanilla ice cream
Whole milk
Pepper
Instant coffee
Sugar
Canned peaches
2.6 grams NaCI for the day 3.0 grams NaCl for the day
Armour Frozen Dinners (Hospital Fare - Modified Diet)
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TABLE C
CALCULATED NUTRIENT COMPOSITION OF SEMI-METABOLIC DIETS
Nutrient
Calories
Carbohydrate
Fat
Protein
Nitrogen
Calcium
Phosphorus
Sodium
Potassium
Magnesium
Iron
Vitamin A
Thiamin
Ribof lavin
Niacin
Vitamin C
Unit
grams
grams
grams
grams
mg.
mEq.
mg.
mg.
mEq.
mg.
mEq.
mg.
mEq.
mg.
IU
mg.
mg.
mg.
mg.
Subject
Menu 54
2768
281.6
133.2
110.7
17.71
1157
57.73
1631
3336
145.04
3734
95.74
298
24.50
12.3
5952
2.94
3.36
38.4
152
3
Menu 56
2770
268.5
140.4
108.2
17.31
1251
62.42
1717
3269
142.13
3534
90.61
334
27.46
15.4
10,737
1.45
2.57
18.6
80
Subject
Menu 53
2589
265.7
120.5
110.5
17.68
1152
57.48
1725
3326
144.60
3795
97.30
342
28.12
11.9
5482
2.94
3.26
38.9
152
4
Menu 55
2602
256.1
126.9
109.0
17.44
1249
62.32
1831
3278
142.52
3520
90.25
375
30.83
15.0
10,186
1.40
2.47
19.2
72
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TABLE D
CALCULATED NUTRIENT CONTENT OF DIETS FOR SUBJECTS 5 and 6
Nutrient
Calories
Nitrogen
Protein
Fat
Carbohydrate
Alcohol
Calcium
Phosphorus
Sodium
Potassium
Magnesium
Iron
Vitamin A
Thiamin*
Riboflavin*
Niacin*
Vitamin C*
Vitamin D
Folacin
Vitamin Bfi
Vitamin B-^
Iodine
Cholesterol
Unit
grams
grams
grams
grams
grams
mg.
mg.
mEq.
mEq.
mg.
mg.
IU
mg.
mg.
mg.
mg.
IU
meg.
meg.
meg.
meg.
mg.
1
2506
17.23
107.7
92.2
290.6
11.9
991
1670
129
88
269
18.3
8318
3.08
5.14
42.3
244
641
172
2342
9.8
108
697
Menu Number
2
2518
17.31
108.2
104.0
268.3
10.8
1002
1651
130
77
265
13.2
9094
2.92
5.15
48.9
150
847
71
2407
9.1
116
606
v
3
2493
14.83
92.7
72.2
350.8
9.9
999
1572
130
63
319
12.5
8202
3.02
4.13
46.0
117
474
125
1107
1.9
96
202
7 -day Mean
2506
16.56
103.5
89.8
301.4
11.0
996
1636
130
77
282
15.1
8506
3.01
4.85
45.2
181
652
130
2030
7.3,
107
530
Values include nutrients in one Hexavitamin
tablet, which was administered daily from
(B13) through (R'14).
Menu Rotation:^ 1-3 times weekly.
# 2 - twice weekly
# 3 - twice weekly
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TABLE E
DIET ANALYSIS
(meq/24 hrs)
Subjects 5 and 6
Day
A 5
A 9
A 10
B 13
B 14
B 15
B' 1
B1 2
B1 3
B'13
B'14
B'15
Diet 1
Diet 2
Diet 3
Diet Number
3
1
2
1
2
3
2
3
1
1
2
3
Sodium
Analyzed Calculated
133.2 129.0
121.7 130.3
122.9 130.1
Sodium
123.8
134.9
120.8
135.4
124.5
124.0
118.6
124.6 "
129.2
133.3
122.8
119.2
Averages
Potassium
64.2
82.2
73.5
81.6
73.1
65.6
74.4
65.2
78.4
80.8
75.4
64.3
Potassium
Analyzed Calculated
80.8
74.0
64.8
87.6
77.1
62.8
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Menu # 1
Breakfast
TABLE F
MENUS FOR SUBJECTS 5 and 6
Menu # 2
Breakfast
Menu # 3
Breakfast
Orange juice
French toast (2 si.)
Butter
Brown sugar w/cinnamon
Whole milk
Instant coffee
Sugar
Pepper
Lunch
Cheeseburger
White toast (2 si)
French Fried Potatoes
Catsup
Strawberry Shortcake
(Angel cake, straw-
berries, Cool Whip)
Coca Cola
Pepper
Dinner
Cabernet Sauvignon
Beef Tenderloin
Brown rice
Asparagus (canned)
Whole wheat bread (1 si)
Butter
Vanilla ice cream
Pepper
Tomato juice Grape juice
Omelet w/Bac-o-Bits Peaches (canned)
Whole wheat toast (1 si) Wheat Ghex
Butter
Jelly
Whole milk
Pepper
Whole wheat toast (1 si)
Butter
Jelly
Whole milk
Sugar
Lunch Lunch
Tuna Sandwich (1 1/2) Green Pea Soup
Jello w/Mandarin oranges Grilled cheese sandwich
Vanilla wafers Orange sherbet
Lemonade Wine Cooler (Johannisberg
Whole milk Riesling w/Seven Up)
Pepper Pepper
Dinner
Spaghetti & Meatballs
w/Tomato sauce
Parmesan cheese
Whole kernel corn
(canned)
Whole wheat bread (1 si)
Butter
Light Choc. Cool 'n
Creamy Pudding
Heineken Beer
Pepper
Dinner
Chicken Casserole (chicken,
macaroni, peas)
Green beans (frozen)
Whole wheat bread (1 si)
Butter
Butterscotch Cool 'n
Creamy pudding
Cookie (1)
Whole milk
Pepper
Snack
Canned pears
Cookie (1)
Whole milk .
2.5 grams NaCl
for the day
Snack
Graham crackers w/
peanut butter
Whole milk
0.4 grams NaCl
for the day
Snack
Peanut butter & jelly
sandwich
Pineapple (canned)
No NaCl in a salt
shaker
-13-
Sample menus for the three diets are shown in Table F.
3. Methodology
a. Biochemical Methods - All studies were performed in
duplicate.
1) Sodium and potassium were determined iri serum,
urine, and diet by standard techniques using an
Instrumentation Laboratories flame photometer,
Model 143.
2) Hematocrits were determined in standard fashion.
The value used was an average of duplicate deter-
minations on seven samples of blood drawn over a
six hour period.
3) Creatinine was determined in urine by use of a
Technicon Autoanalyzer.
b. Multiple Isotopic Volume Studies
In the performance of multiple isotope studies on
repeated occasions the total body radiation dosage was less than
150 mr/week. The method used to achieve this, and the specific
methods involved in the calculation of plasma volume, extracellular
fluid volume, red cell mass, and total body water have been detailed
in earlier publications from this laboratory.
c. 70° Tilt Studies
Tilt studies were performed on Subjects 1 and 2 after
morning urine close-out. The patient was transported in the
horizontal position from his room to the tilt table which was
equipped with an English saddle. EKG was measured by a modified
Lead II using three chest electrodes, and beat to beat heart rate
was measured by a tachometer triggered by the R wave of the QRS
complex. Reproducible basal heart rate and manual cuff blood
-14-
pressure measurements were made. The subject was then placed in a
70° foot down tilt. The tilt was maintained for 20 minutes unless
presyncopal symptoms (symptomatic hypotension) or syncope occurred,
at which time the patient was returned to the horizontal position.
EKG and heart rate were recorded continuously, and blood pressure
was measured every 30 seconds during the tilt and for the first
five minutes of recovery; and these parameters were checked again
at ten minutes following cessation of the tilt. On Day B'15 the
tilt was performed with each subject wearing a G-suit inflated to
43 inches HO.
d. Lower Body Negative Pressure (LBNP) Studies
The LBNP studies were performed in Subjects 3,4,5 and 6
following morning urine, close-out. The subject was transported to
the LBNP device in a horizontal position. The lower portion of the
body, from the iliac crests downward, was positioned in the LBNP
box while the upper portion of the body remained on a guerney.
The device used for the study was an appropriately cushioned
rectangular shaped box constructed of plywood and with a rubber
(3)
waist seal and sheet design as described by Wolthuis et al.
The vacuum was generated by a commercial vacuum cleaner, and the
negative pressure measured by a Wallace & Tiernan Model FA141
differential- pressure gauge. Blood pressure was measured by
auscultation with a cuff above a brachial artery, and EKG from a
modified chest lead. Instantaneous heart rate was derived from
this EKG by a cardiotachometer and was simultaneously displayed on
-15-
an oscilloscope and continuously recorded on photographic paper.
After baseline measurements of blood pressure and heart rate were
stable, the subject was exposed successively to -30mmHg, -40mmHg,
and -SOmmHg negative pressure for periods of five minutes each.
At the end of the study the vacuum was released immediately.
Blood pressure was measured every 30 seconds and heart rate
continuously during LBNP, and both parameters were measured at
1,2,3,4,5, and 10 minutes after return to normal atmospheric
pressure. If at any time the volunteer felt presyncopal and/or
the systolic blood pressure fell below 85 mmHg, the study was
terminated.
e. Exercise Studies
Following completion of the 70° tilt or. LBNP study, the
subject was allowed to return to baseline blood pressure and heart
rate values and was transferred in the horizontal position to an
exercise table to which a Godart Lanooy Ergometer was attached.
Four power levels were used in this study: 50 watts, 75 watts,
100 watts, and in Subjects 3,4,5 and 6 either 125, 150 or 175
watts depending on the level which was predicted to induce a heart
rate in excess of 160/minute in the individual subject at that
time. Each exercise level was sustained for six minutes.
When blood pressure and heart rate measurements were stable,
the subject began pedaling at a rate of 50 revolutions per minute
(rpm) and the ergometer was then set to the particular power level
desired. Blood pressure was measured by auscultation at 3 and 6
minutes. EKG and instantaneous heart rate were continuously recorded.
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At each exercise level oxygen consumption between minutes 4 through 6
was calculated from the volume of expired gas measured in a Tissot
spirometer and the pO~ of the gas measured by a Clark type oxygen
electrode. Following termination of the highest exercise level the
blood pressure and heart rate were recorded at 1,2,3,4,5 and 10 minutes.
f. Centrifuge Studies
One day following the tilt or LBNP and exercise studies, the
subjects were transported from the USPHS Hospital, San Francisco to
the NASA-Ames Research Center at Moffett Field, California, a distance
of about 35 miles. During the ambulatory and recovery phases they
were allowed to ambulate and to sit in a car for travel; and during
the bedrest phases they were transferred from bed to guerney to
ambulance bed and were kept in the horizontal position until completion
of the centrifuge studies. All studies were performed between 8:30 AM
and 11:30 AM with the subjects in the fasting state. Physicians were
in attendance throughout the travel and study periods.
During acceleration studies EGG was measured by two sternal
electrocardiographic leads connected to a cardiotachometer, temporal
artery flow velocities were measured by ultrasonic flowmeters placed
over both superficial temporal arteries, and blood pressure was
measured manually by cuff and microphone over the left brachial artery
using a Gemini sphigmomanometry system. Following placement of these
devices, the subjects walked or were carried 30 feet to the Ames
Biosatellite Centrifuge into which they were secured. Acceleration
tolerance was assessed by a subject's response to peripheral lights
presented in a random fashion, by his ability to perceive a central
white light of 15 foot candles luminence, and by the presence or absence
-17-
of Doppler flow velocity signals from the superficial temporal arteries.
All data were continuously recorded on a Brush 8 channel direct writing
recorder and on an Ampex FR 1800 tape recorder. All subjects were
instructed not to perform straining maneuvers during acceleration
procedures. Throughout the studies voice communication was maintained,
and there was constant visual monitoring of the subject by means of
infrared television.
The +G centrifuge profiles consisted of three runs separated by
z
five to ten minute rest and equilibration periods., The runs consisted
of: 1) 2.1 G for 670 seconds; 2) 3.2 G for 220 seconds; and
3) 3.8 G for 185 seconds. The rate of change of acceleration was
1.8 G per minute; and the rate of change on deceleration was about
this level when the subject had completed a run uneventfully, and much
faster (up to 18 G/min) when presyncope or syncope occurred. The seat
back angle was adjusted just prior to the start of centrifugation,
with the head upward to 30°, 19.5°, and 16.6° above the horizontal
plane for the +2.1, +3.2, and +3.8 G runs, respectively, in order to
maintain a full component vector of the acceleration along the long
axis of the body.•
At the completion of the second bedrest period of Subjects 1,2,
3 and 4, and of the first bedrest period of Subjects 5 and 6, an
inflated G-suit was worn. The specific suit employed was the Air Force
cutaway anti-G garment CSU-3/P inflated to 13 inches of t^ O, 45 inches
of H00, and 60 inches of H00 for the +2.1, +3.2, and +3.8 G runs,L . f. Z
respectively. At all other times no counter-pressure device was used.
Following completion of the studies the subjects were allowed
to rest and to eat or drink a portion of their metabolic diet ad Ub.
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They were then returned to the USPHS Hospital, San Francisco by car
or ambulance.
C. Results
1. Analysis of Data: In this study data were accumulated on all
of the parameters discussed above during all phases of the study. In
evaluating the data in the different phases, attention was directed
not only to the effects of the bedrest periods relative to the ambula-
tory control and recovery periods, but also to the recovery periods
relative to the ambulatory control period. Interest in this latter
aspect has been prompted by earlier studies in this laboratory which
have shown that following a two week bedrest period, certain parameters
may require a two week or longer recovery period to return to their
ambulatory control values.
In analyzing the data, group means and standard errors (95%)
were calculated, and significances of values in different periods or
under different circumstances were determined by use of the paired
(4\
"t" test. A P value of <0.05 was considered to document a
significant difference.
2. General Data: Table 1 contains the height, the initial and
final weights, and problems encountered by each subject during the
course of the study.
3. Sodium Balance Studies: The sodium balance, calculated as
the dietary sodium intake (Table 2) minus the urine sodium output
(Table 3), is shown in Table 4 and Figure 1. This balance obviously
disregards stool sodium and insensible sodium losses which should have
been relatively constant and insignificant during all phases of this
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study. Since dietary sodium intake was essentially constant, the
sodium balance gives a relative estimate of extracellular fluid
volume changes as reflected in urinary sodium excretion during the
different phases of the study.
Table 4 and Figure 1 show that the effect of the tilt and
exercise (Subjects 1 and 2) is to significantly increase positive
sodium balance when compared with the previous days during both
bedrest and non-bedrest phases. This same phenomenon is seen in
13 of 16 instances of LBNP and exercise in Subjects 3,4,5 and 6.
Since exercise in the absence of tilt or LBNP was not performed, no
conclusions can be drawn of the relative importance of exercise in
inducing the sodium retention.
Table 4 also reveals a markedly negative sodium balance on Day Bl
in 5 of 6 subjects and on Day B'l in all subjects; on Day B2 in 3 of 6
subjects; and on Day B'2 in 5 of 6 subjects. The response is most
marked on the first bedrest day in 9 of 12 instances and on the
second bedrest day in the remaining three. Further, the initial
days of recovery periods are characterized by a markedly positive
sodium balance, the most markedly positive balance occurring on the
first recovery day in 11 of 12 instances, and on the second recovery
day in the remaining instance.
The mean values of the six subjects clearly demonstrate the
t
increase in sodium balance on the tilt or LBNP and exercise days;
the markedly negative sodium balance on the first bedrest days
(Rl, B'l) and the less marked but still quite negative balance on
the second bedrest days (B2, B'2); the markedly positive sodium
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balance on the first recovery days (Rl, R'l), and less marked but
still quite positive balance on the second recovery days (R2, R'2).
Table 5 shows the average sodium balance per day during the different
phases of the study, excluding the stress (i.e., tilt or LBNP and
exercise) days at the ends of the periods. Here again the lower
sodium balance in the bedrest relative to the recovery and ambula-
tory periods is demonstrated. These are the typical sodium balance
responses to bedrest and resumption of normal upright activity which
have been established in our laboratories, and document a physiologic
n 2)
response to the bedrest period. ' '
Statistical evaluation of the sodium balance during different
phases of the study (Table 5 and Figure 2) shows significant decreases
in sodium balance when the second bedrest period is compared with the
first and second recovery periods. As expected, there are no significant
differences between the ambulatory control and the first and second
recovery periods. The failure of the overall results to show a signifi-
cant decrease in sodium balance during the first bedrest period when
compared with either the ambulatory control period or the first
recovery period requires discussion. The mean daily sodium balance
for Days B 1-14 was -1.9 meq/24 hrs versus 10.1 meq/24 hrs and
15.6 meq/24 hrs for the ambulatory control and first recovery periods,
respectively. Four of the six subjects showed the proper trend.
Subject 3 showed little change and Subject 1 showed a marked change
to positive rather than negative sodium balance. These latter two
results cause a large standard error which prevents achievement of
significance. The atypical results in these subjects may have been
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due to unknown or undetected variations in their diets, since
neither was on a true metabolic diet. Also, it is possible that
neither subject had reached full equilibration with the diet by
the beginning of the ambulatory control period, since both showed
the expected decrease in sodium balance during the second period
of bedrest. In the case of Subject 1, the low urinary creatinine
values on Days B 8-14 (Table 12) suggest inaccuracies in urine
collection which would result in a higher calculated balance.
These results do point up the difficulties inherent in interpreting
data from small numbers of subjects in non-metabolic circumstances.
Subjects 5 and 6 who received accurately evaluated metabolic diets
consistently showed the expected changes in sodium balance.
4. Potassium Balance Studies: The potassium balance, Table 8
and Figure 2, is calculated from the dietary potassium intake
(Table 4) minus urinary potassium excretion (Table 7). This calcula-
tion excludes stool and insensible potassium losses which are small
and should be constant during all phases of the study. When the
balances are calculated for each period on days when no stresses
are applied to the subjects (Table 9), it is seen that the potassium
balance is lower during bedrest periods when compared with the
ambulatory control and recovery periods in five of the six subjects.
This decrease in potassium balance is the usual response to
bedrest and recovery established in this laboratory, and has been
attributed to loss of potassium from muscle breakdown during
bedrest periods.
These potassium balance differences achieved statistical
-22-
significance when the first bedrest period is compared with the
first recovery period, and when the first recovery period is compared
with the second bedrest period (Figure 2). There were no significant
differences between the ambulatory control and first recovery and
between the first and second recovery periods, as is expected.
The failure to achieve statistical significance when the first
bedrest period is compared with the ambulatory control period can
be attributed to the atypical response of Subject 1. The possible
reasons for the atypical response have been discussed under Sodium
Balance Studies (vide supra).
5. Fluid Balance Studies: The results of fluid balance studies,
i.e., oral intake minus urine output, are shown in Tables 10 and 11.
These balances obviously neglect stool and insensible fluid losses
which should have been relatively constant during all phases of the
study. Table 11 and Figure 2, displaying the group means during
different phases of the study, show statistically significant
lower fluid balances during the two bedrest periods when compared
with the ambulatory control and first recovery periods and no
significant differences between the ambulatory control and recovery
periods. This is the typical response to bedrest as previously
documented in these laboratories.
6. Urine Creatinine Studies: The results of urinary creatinine
excretion determinations are shown in Table 12. The values in each
subject, with few exceptions, are essentially constant throughout
the study.
7. Serum Chemistries: The serum sodium and potassium values
of each subject on particular study days are shown in Table 13.
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These values are within normal limits in all subjects throughout
the entire study.
8. Body Fluid Compartment Studies: Detailed results of plasma
volume (PV), red cell mass (RCM), extracellular fluid volume (EFV),
total body water (TBW), and body weight are presented in Table 14.
Group means on particular study days are shown in Table 15 and in
Figure 3. It is seen that the PV is the first body fluid compartment
to have a statistically significant change during bedrest periods
when compared to ambulatory control and recovery periods. The PV
decreases by the second bedrest day (significantly in the second
bedrest period) and continues to decrease throughout the bedrest
periods. During recovery periods it rises to pre-bedrest values,
and there are no significant differences in PV between the ambula-
tory control, first recovery, and second recovery periods.
The EFV and TBW also demonstrate consistent changes during
bedrest periods, both decreasing. Although the decrease is
measurable on the second bedrest days, the decrease achieves
statistical significance only later in the bedrest periods. Thus,
EFV and TBW achieve statistically significant decreases during
bedrest periods more slowly than PV. As with PV, there are no
significant differences in EFV and TBW between the ambulatory
control and first and second recovery periods.
Red cell mass shows a consistent decrease throughout the
study, attributable to blood withdrawal. The decrease between
contiguous two week periods is not statistically significant.
However, the decrease is significant when R9 is compared with
-24-
the mean ambulatory control value. Results of hematocrit deter-
minations on study days are shown in Table 16.
9. Responses to 70° Tilt: The heart rate, blood pressure,
and pulse pressure responses to 70° tilt are shown in Tables 17,
18, 19 and in Figure 4. It is noteworthy that the maximum heart
rate achieved was much greater, and the minimum pulse pressure
much lower, following the first bedrest period than on the previous
ambulatory control or subsequent recovery periods. With the use of
G-suits inflated to 43 inches of water in the tilts following the
second bedrest period, the heart rates of both subjects were lower
than during tilt in the ambulatory control, first bedrest, arid
recovery periods. The pulse pressure of Subject 1 during the
G-suit tilt was greater than or equal to that in the ambulatory
control, first bedrest, and recovery periods; whereas in Subject 2
it was in the same range as during the initial bedrest period, and
well below the ambulatory control and recovery period values.
Although Subject 2 experienced presyncopal symptoms during tilt
following both bedrest periods, these symptoms appeared much
(five minutes) later when the G-suit was used. Thus, in both
patients the G-suit gave increased orthostatic tolerance in the
post-bedrest state. Subject 2, however, complained of significant
abdominal pain when the G-suit was inflated, and continued to have
abdominal tenderness .for 48 hours after the tilt. This abdominal
trauma may well have contributed to the hypotensive episode during
tilt.
10. Lower Body Negative Pressure (LBNP) Studies: The heart
rate responses of Subjects 3,4,5 and 6 to LBNP are presented in
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Tables 20, 21, 22 and 23. Reference to Table 20 and Figures 5a and
5b shows that several heart rate responses are common to all subjects.
Firstly, in all subjects on all study days the average and maximum
heart rates were lowest during the -30mmHg and highest during the
-SOmmHg periods. Secondly, comparing all levels of LBNP on all
study days, it is seen that the highest average and highest maximum
heart rates achieved during LBNP occur following the bedrest periods
and at the highest tolerated level of negative pressure. Focusing
on responses at the -SOmmHg level which, being the most stressful
is most likely to bring out differences in response, it is seen
that the average and maximum heart rates in studies following bedrest
are greater than in the ambulatory control and recovery periods in
Subjects 3,4 and 5. Subject 6 experienced syncope and presyncope
during his two post-bedrest studies and was, therefore, quite
anxious during the last three LBNP studies. Perhaps it is for
this reason that his heart rate responses are less in accord with
those of the other subjects, i.e., higher during the two recovery
periods than following the first bedrest period.
Statistical analysis of the group means of the maximum heart
rate responses are shown in Table 23. Note that there is a
significantly higher heart rate at rest as well as during all
levels of LBNP during the first post-bedrest study when compared
with the ambulatory control period results. During the study
following the second bedrest period (B'15), the group means
±S.E.(95%) were nearly identical to those on B15 at all levels
of LBNP. However, statistically significant differences with R13
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were achieved only at the -SOmmHg level. This suggests that not
all subjects had returned to their ambulatory control status by R13.
This possibility is strengthened by the fact that the group results
on R13 did not differ significantly from those of B15. The fact
that the group contained some subjects who had returned to control
levels is suggested by the failure to show statistically significant
differences between R13 and A13. The same findings exist in the
comparison of B'15 with R'14 and R'14 with R13. Thus, in reviewing
data from groups with a small number of subjects such as this,
individual results and group means ±S.E.(95%) must be considered
along with P values in the interpretation of results.
Table 24 shows that during LBNP there is a definite fall in
systolic blood pressure throughout the LBNP period on all study
days in Subjects 4,5 and 6, and on Days A13 and B15 in Subject 3.
However, the drop is of the same magnitude following bedrest
periods as during ambulatory control and recovery periods. There
is no consistent change in magnitude or direction of the diastolic
blood pressure in these studies, but in most instances the net
result is a fall in the pulse pressure (Table 25). However, the
magnitude of the pulse pressure fall is similar in the bedrest
and non-bedrest studies.
11. Response to Exercise: Table 26 shows that the heart rate
response to various levels of exercise is not consistently different
in magnitude or direction when bedrest periods are compared with
the ambulatory control and recovery periods. Neither is there a
dramatic difference in oxygen consumption at various levels of
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exercise during these periods (Table 27). However, when, maximal
oxygen uptake is calculated by linear extrapolation of heart rate
and oxygen consumption data, ' ' several correlations are seen.
Table 28 and Figure 2 show significant differences in derived
maximal oxygen uptake between the ambulatory control and first
bedrest periods, between the first bedrest and the first recovery
periods, between the first recovery and second bedrest periods,
and between the second bedrest and second recovery periods. Also,
there are no significant differences in these derived values
between the ambulatory control and first recovery periods, and
between the first and second recovery periods. Thus, cardiovascular
performance, as reflected in the derived maximal oxygen uptake,
appears to deteriorate during a two week bedrest period and to
recover to pre-bedrest levels following a two week recovery period.
This decrease in maximal oxygen uptake occurred in nine of ten
measurable comparisons of post-bedrest with pre-bedrest results.
12. Centrifuge Studies: The heart rate responses to centri-
fugation are shown in Tables 29, 30 and 31 and in Figures 6 through 11.
The maximum heart rates in all subjects at all +G levels, with one
z
instance excepted (+3.8 G , Subject 2, Table 31, vide infra) were
Z "
greater in the post-bedrest runs without G-suits than in the ambula-
tory control and recovery periods. Specifically, the maximum heart
rates in the bedrest without G-suit runs exceeded those in the
ambulatory control period runs by 20 to 48 (mean 32) at +2.1 GZ>
by 8 to 34 (mean 20) at +3.2 G , and, with the one exception, by
Z
12 to 53 (mean 25) at +3.8 G . They likewise exceeded those in
* Z
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the recovery period runs by similar values: 7 to 48 (mean 33) at
%
+2.1 G , 11 to 44 (mean 24) at +3.2 G , and with the one exception,
.z z
20-32 (mean 24) at +3.8 G . When the heart rate responses in the
Z
post-bedrest runs with and without G-suits are compared, a signifi-
cant effect of the G-suit on lowering heart rate is demonstrated.
With the G-suit the post-bedrest maximum heart rates were lower
than without G-suits by 5 to 50 (mean 24) in the +2.1 G runs,
Z
by 4 to 50 (mean 22) in the +3.2 G runs, and (with the one
Z
exception) by 0 to 40 (mean 21) in the +3.8 G runs. In fact,
Z
the maximum heart rates in the post-bedrest runs with G-suit were
in most instances very close to, and at times lower than, those in
the comparable ambulatory control and recovery period runs.
Subject 2's atypical maximum heart rate response at +3.8 GZ,
i.e., lower in the bedrest without G-suit run than in the ambulatory
control and recovery period runs, suggests increased vagal tone in
this run. Such a response may have been related to the presyncopal
symptoms which the patient had experienced in the immediately preceeding
+3.2 G run on BR-. In Subject 4's +2.1 G,, run with G-suit, the
z z
G-suit spontaneously deflated early in the run. However, the run
was completed. It is noteworthy that in this instance the heart
rate response was essentially identical to that during the earlier
post-bedrest without G-suit run.
Statistical analysis of the group means of the maximum heart
rates during centrifuge studies are shown in Table 32 and Figure 11.
Since some subjects wore the G-suit in the run following the first
bedrest period (Rl) and others in the run following the second bedrest
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period (R'l), the post-bedrest data are evaluated on days on which a
subject wore (BR+) or did not wear (BR-) the G-suit. Since the G-suit
deflated during Subject 4's +2.1 G run on R'l, this datum is excluded
z
from the BR+ group and added to the BR- group. Note that in the
post-bedrest runs without G-suits (BR-), the maximum heart rates
achieved are significantly higher than in the ambulatory control,
recovery, and post-bedrest with G-suit (BR+) runs at the +2.1 G
Z
and +3.2 G levels, and higher than in the recovery and BR+ period
Z
runs at +3.8 G . Further, it is noteworthy that there are no
Z
significant differences in maximum heart rate response between the
post-bedrest with G-suit (BR+) and the ambulatory control or recovery
period runs at all +G levels, indicating that the post-bedrest use
Z
of the G-suit in this study normalized the post-bedrest maximum heart
rate response.
At the +3.8 G level, statistically significant higher maximum
heart rates were not achieved in the post-bedrest without G-suit
run relative to the ambulatory control period. Statistically, the
lack of significance is attributable to Subject 3's very low
maximum heart rate on A14, giving a large standard error.
Perhaps of greater practical significance than maximum heart
rate response is the fact that subjects who had previously terminated
the post-bedrest runs prematurely were able to tolerate the runs for
significantly longer periods of time with the G-suit than without it.
It permitted Subjects 2 and 6 the 5 and 54 seconds, respectively,
needed to complete the +3.2 G run, and Subject 1 the 55 seconds
Z
to complete the +3.8 G run. Also, in the +3.8 G run it allowed
Z Z
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Subject 2 102 seconds and Subject 6 124 seconds longer tolerance
than in the bedrest without G-suit run.
However, some complications related to the use of G-suits
occurred. All subjects developed some asymptomatic petechiae of
the feet and ankles, but Subjects 5 and 6 also developed painful
edema of the toes and feet which gradually disappeared over a 12
hour period.
It is noteworthy that those subjects who developed visual
impairment during centrifugation experienced peripheral light loss
(PLL) before central light loss (CLL). However, when CLL did occur
it followed PLL by only a few seconds. The one instance of loss of
consciousness (Subject 6, +3.2 G run, R14) occurred within seconds
z
following CLL as the subject was stating that CLL was occurring.
In all instances of PLL and CLL the ultrasonic flowmeter signals had
indicated zero flow for at least several seconds prior to the onset
of visual impairment.
D. Discussion
This study attempted to 1) document and quantify a "bedrest
effect" by metabolic studies and cardiovascular stress tests, and
2) evaluate the influence of this bedrest effect on tolerance to
a specific +G acceleration with and without the use of the G-suit.
Both of these aims were achieved.
The bedrest effect was documented in several ways. The sodium
balance, dependent on the renin-angiotensin-aldosterone system
which is partly a gravity-activated system, was lower during bedrest
periods than during periods of upright posture. The fluid balance,
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dependent largely on changes in sodium balance, was also lower
during bedrest periods. The potassium balance, presumably reflecting
changes in body muscle mass, diminished during bedrest. The plasma
volume, extracellular fluid volume, and total body water volume also
decreased during bedrest periods. The maximum heart rate response
to 70° tilt and LBNP, and the duration of tolerance to these stresses
in those individuals who developed syncope demonstrated lower ortho-
static tolerance following bedrest. Finally, the lower calculated
maximum oxygen uptake from exercise studies following bedrest documents
deterioration in cardiovascular performance. .
The data obtained in the 4G profiles used here should accurately
z
predict the responses of passengers re-entering the earth's atmosphere
in the Space Shuttle Vehicle using an identical +G profile following
•. z
a two week exposure to the weightless environment. Specifically, some
untrained passengers re-entering the earth's gravitational field at
these 4G in the unprotected state will have higher heart rates and
z
will experience visual impairment earlier than in the control state.
Some passengers may even become syncopal. However, the wearing of the
Air Force cutaway G-suit inflated to the pressures used here should
normalize the heart rate responses and prolong the time to visual
impairment in all passengers. Nevertheless, some lay personnel
may still experience visual impairment or syncope. For such individuals,
additional G protection, e.g., straining maneuvers or higher G-suit
pressures, would have to be employed.
A most important objective, then, is the selection of persons who
will be able to tolerate s specific -KJ profile following specific
Z
periods of weightlessness. In the specific +G profile used in this
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study, Subjects 1,2 and 6 were unable to tolerate the acceleration
stresses following the two week bedrest period in the unprotected
state. Although the use of the inflated G-suit allowed Subject 1
to tolerate the 4G profile, Subjects 2 and 6 were still unable to
z
complete it. And if catastrophes are to be avoided, persons like
Subjects 2 and 6 must be identified.
Since admission into this study required an ambulatory subject
to tolerate a 70° passive tilt, it is clear that this orthostatic
tolerance test will not be of high enough selectivity in ambulatory
subjects. Further, the fact that Subjects 3,4,5 and 6 in addition
tolerated the LBNP profile used here during the ambulatory control
period indicates that this test, used in ambulatory subjects, also
will not be adequately selective. Following two weeks of bedrest,
however, Subjects 2 and 6 were intolerant to tilt and LBNP suggesting
that performance of these tests following a two week bedrest period
will identify some of the people at risk. Such a long bedrest period
as a screening procedure is obviously impractical. Our studies have
demonstrated decreases in plasma and extracellular fluid volumes, and
/a\
others ' have demonstrated diminution in 70° passive tilt tolerance
which occurs within 48-72 hours of bedrest. Thus, it is possible
that orthostatic tolerance tests may achieve the required selec-
tivity after an abbreviated period of bedrest.
The heart rate responses and tolerances to centrifugation
documented in this study are similar to those obtained in studies
with somewhat different protocols and aims. ' ' Specifically,
it has been shown that +G tolerance, measured by several endpoints,
z
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deteriorates following periods of bedrest. ' Further, the use
of the inflated G-suit has been documented to give increased -+G
z
tolerance in the control as well as the post-bedrest state; '
although in the present study its use seemed to worsen petechial
hemorrhages on the feet and ankles. It is possible that +G tolerance
Z
in our subjects may have been increased to a greater extent than
observed had the G-suits been tailored to the individual subject
and had pressures in the G-suits been different. Others have found
that subjects wearing the best fitting G-suits, inflated almost to
the point of discomfort at 1 G, had the best -KJ tolerance, '
Z
although specific inflation pressures have not been published.
Finally, it has been observed that straining maneuvers may result
in increased -K5 tolerance, ' suggesting that the performance of
z
such a maneuver in our study might have supplemented the increased
•fG tolerance afforded by the inflated G-suit alone.
z
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TABLE 1
GENERAL DATA
Subject
1
2
Height (cm)
176
182
3
4
5
175
177
185
Weight (kg)
Initial Final
65.13
98.23
64.78
97.05
79.96 80.37
72.42 71.96
69.54 68.10
Noteworthy Events
During Study
Abdominal pain and bruise
from poorly fitting G suit
during tilt.
Extensive edema and purpura
of feet in post-bedrest with
G suit centrifuge runs.
179 72.52 70.70 Same as 5.
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TABLE 2
SODIUM INTAKE
(tneq/24 hrs)
Day of Study
Subject
3 5 and 6
A 1
A 2-7
A 8-12
A 13
A 14
B 1
B 2
B 3-7
B 8-14
B 15
R 1
R 2
R 3-7
R 8-12
R 13
R 14
B1 1
B1 2
B1 3-7
B1 8-14
B1 15
R1 1
R' 2
R1 3-7
Rf 8-13
160
160
160
160
160
160
160
160
160
160
160
160
160'
160
160
160
160
160
160
160
160
160
160
160
160
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
157
145
' 144
144
145
142
145
142
144
144
145
142
145
143
144
142
145
142
145
143
144
142
145
142
144
145
144
144
145
142
145
142
144
144
145
142
" 145
143
144
142
145
142
145
143
144
142
145
142
144
135
126
127
121
122
133
123
126
127
133
123
133
126
127
122
133
123
133
126
127
123
133
122
127
128
Pay of Study
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TABLE 3
URINE SODIUM EXCRETION
(meq/24 hrs)
Subject
A 1
A 2-7
A 8-12
A 13
A 14
B 1
B 2
B 3-7
B 8-14
B 15
R 1
R 2
R 3-7
R 8-12
R 13
R 14
B' 1
B« 2
B1 3-7
B' 8-14
B1 15
R1 1
R1 2
R' 3-7
R1 8-13
151
154
148
102+
115*
225
154
163
113
98+
99*
161
144
152
113+
150*
239
171
165
151
117+
174*
108
146
159
174
116
130
116+
75*
186
208
142
219
120+
59*
93
149
129
122+
85*
214
207
138
140
H5+
111*
115
145
133
188
146
129
105+
135*
101
183
142
140
111+
84*
133
136
132
150+
92*
169
144
126
144
134+
71*
89
123
190
122
133
88+
127*
190
162
126
132
93+
63*
" 122
124
118
100+
80*
275
168
133
129
86+
58*
72
120
121
119
123
130+
97*
273
80
115
130
128+
30*
91
164
109
137+
84*
189
152
118
132
72+
60*
169
130
119
110
124
130
92+
83*
211
101
119
133a.
13 7+
52*
97
135
125
101+
69*
144
184
128
126
4-
78+
74*
101
133
116
\
Centrifuge Day
Tilt (Subjects 1,2) or LBNP (Subjects 3,4,5,6) and Exercise Day
=39.
TABLE 4
SODIUM BALANCE
(meq/24 hrs)
(Intake minus urine Output)
Subject
D a y o f Study 1 2 3 4 5 6 Mean
A 1
A 2-7
A 8-12
A 13
A 14
B 1
B 2
B 3-7
B 8-14
B 15
R 1
R 2
R 3-7
R 8-12
R 13
R 14
B' 1
B' 2
B1 3-7
B1 8-14
B1 15
R1 1
R1 2
R' 3-7
R' 8-13
*
Centrifuge Day
+Tilt (Subjects 1,2) or LBNP (Subjects 3,4,5,6) and Exercise
9
6
12
58+
45*
65
6
3
47
62+
61*
'1
16
8
47+
10*
79
11
• 5
9
43+
14*
52
14
1
-17
41
27
41+
82*
-29
-51
15
-62
27+
98*
64
8
28
35+
72*
-57
-50
19
17
42+
46*
42
12
24
-43
- 2
15
40+
7*
44
-41
2
4
34+
58*
12
7
12
- 8+
53*
-27
1
17
0
8+
74*
53
21
-45
22
11
57+
15*
-45
-20
18
12
52+
79*
23
19
26
42+
65*
-133
-23
10
15
56+
87*
70
24
14
7
4
- 9+
25*
-140
43
11
- 3
5+
93*
42
. -38
18
-15+
49*
-66
-19
8
- 5
51+
73*
-47
- 3
9
25
2
- 3
29+
39*
-78
22
7
- 6
- 4+
71*
36
- 9
2
21+
64*
-21
-51
- 2
45+
59*
21
- 6
12
-9
13
11
36+
36*
-52
- 7
8
- 1
29+
77*
29
0
16
20 +
52*
-64
-26
8
6
41 +
54*
32
10
12
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TABLE 5
SODIUM BALANCE
(meq/24 hrs)
Subject A 1-12 B 1-14
1 8.8 18.2
2 30.3 -31.4
3 1.7 2.9
4 11.8 7.8
5 6.3 -4.5
6 1.8 -4.5
Mean 10.1 -1.9
S.E.(95%) ±11.2 ±17.6
P
B vs A
R vs B
B1 vs R
R' vs B1
R vs A
R1 vs R
Day of Study
R 1-12
15.0
28.5
13.8
27.2
2.9
6.0
15.6
±11.1
Values
<0.3
<0.2
<0.005
<0.01
<0.2
<0.4
B1 1-14 R' 1-7
-3.7 15.4
7.6 21.1
4.2 33.1
-0.1 39.6
-5.7 1.6
-5.4 7.1
-0.5 19.6
±5.7 ±15.4
"Page missing from available version"
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TABLE 6
POTASSIUM INTAKE
(meq/24 hrs)
Subject
Day of Study 1 2 3 4 5 and 6
A 1
A 2-7
A 8-12
A 13
A 14
B 1
B 2
B 3-7
B 8-14
B 15
R 1
R 2
R 3-7
R 8-12
R 13
R 14
B1 1
B1 2
B1 3-7.
B1 8-14
B1 15
R' 1
R1 2
R1 3-7
Rf 8-13
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
88
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
98
96
93
94
96
91
96
91
94
93
96
91
96
93
94
91
96
91
96
93
93
91
96
91
94
97
93
94
97
90
97
90
94
94
97
90
- 97
93
94
90
97
90
97
93
94
90
97
90
94
82
73
73
74
74
81
65
75
74
81
65
81
75
73
74
81
65
81
75
74
64
81
74
73
76
68
70
79
66+
88
68
74
82+
94
81
87
82+
77
80
79
84+
67
65
66
60+
79
70
69
55+
-43-
TABLE 7
URINE POTASSIUM EXCRETION
(meq/24 hrs)
Subject
D a y o f Study 1 2 3 4
A 1
A 2-7
A 8-12
A 13
A 14 61* 55* 92* 78* 53* 64*
B 1
B 2
B 3-7
B 8-14
B 15
R 1
R 2
R 3-7
R 8-12
R 13
R 14
B1 1
B1 2
B1 3-7
B1 8-14
B1 15
R' 1
R1 2
R1 3-7
R1 8-13
*
Centrifuge Day
+Tilt (Subjects 1,2) or LBNP (Subjects 3,4,5,6) and Exercise Day
73
55
75
60
68+
87*
56
68
69
74+
74*
72
66
76
69
63+
80*
86
72
73
55
80
84
99
82+
52*
88
73
80
73+
52*
73
70
87
79
77+
75*
74
78
75
70
100
95
87
100+
102*
85
80
80
94+
93*
68
88
82
90
94+
91*
94
86
84
93
88
86
93+
69*
93
79
" 73
60+
91*
109
80
86
87
56+
68*
65
72
62
54
72
64
74+
61*
61
61
65
62+
55*
61
58
71
64
52+
65*
58
53
65
68
46
71
72
80+
48*
54
61
65
59+
56*
64
72
77
68
60+
56*
51
45
62
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TABLE 8
POTASSIUM BALANCE
(meq/24 hrs)
(Intake minus urine Output)
Day of Study
A 1
A 2-7
A 8-12
A 13
A 14
B 1
B 2
B 3-7
B 8-14
B 15
Mean
R 1
R 2
R 3-7
R 8-12
R, 13
R 14
B?
B1
B'
B1
B1
1
2
3-7 .
8-14
15
R1 1
R1 2
R' 3-7
R' 8-13
20
18
9
22+
27*
15
33
13
28
20*
1*
32
20
19
14+
14*
16
22
12
19
25+
8*
2
16
15
10
30
24
16+
43*
43
18
14
- 1
16+
46*
10
25
18
25+
46*
25
28
11
19
21+
23*
24
20
23
2
12
7
14+
- 1*
26
- 9
- 1
6
- 4+
-11*
11
13
14
- 3+
3*
23
8
11
3
- 3+
53*
- 3
8
20
13
15
13+
12*
13
- 3
6
8
4+
21*
4
14
21
30+
6*
-19
17
7
7
34+
29*
25
22
15
8
7
14+
21*
19
11
3
10
7+
4*
' 20
14
8
12+
26*
4
23
4
10
12+
16*
16
20
11
3
6
4
19+
10*
13
19
4
2
1+
17*
27
14
8
15+
25*
1
9
- 2
6
4+
25*
23
28
14
12
14
11
16+
19*
22
12
6
9
7+
13*
17
17
15
16+
20*
8
18
7
11
16+
26*
14
19
16
K
Centrifuge Day
Tilt (Subjects 1,2) or LBNP (Subjects 3,4,5,6) and Exercise Day
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TABLE 9
POTASSIUM BALANCE
(meq/24 hrs)
Subject Day of Study
A 1-12 B 1-14 R 1-12 Bf 1-14
1 14.9 22.0 19.2 16.3
2 26.3 9.0 22.9 17.7
3 8.4 3.6 10.9 7.5
4 14.7 6.8 17.1 6.0
5 9.0 ^ 8 . 0 11.1 8.0
6 5.6 5.1 12.6 3.1
Mean ' 13.2 9.1 15.6 9.8
S.E.(95%) ±7.78 ±6.95 ±5.14 " ±6.16
P Values
B vs A <0.30
R vs B <0.05
B1 vs R <0.01
R' vs B' <0.20
R .vs A <0.20
R' vs R <0.50
R1 1-7
12.7
20.9
5.9
23.7
18.9
26.9
18.2
±8.06
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TABLE 10
FLUID BALANCE SUMMARY
(ml/24 hrs)
Subject
D a y o f Study 1 2 3 4
A 1
A 2
A 3
A 4
A 5
A 6
A 7
A 8
A 9
A 10
A 11
A 12
A 13
A 14
B 1
B 2
B 3
B 4
B 5
B 6
B 7
B 8
B 9
B 10
B 11
B 12
B 13
B 14
B 15
828
1129
706
878
104
1191
711
1198
-327
900
1207
1886
732
179
1581
852
404
581
1027
.524
961
562
769
852
1621
-209
278
558
381
225
381
661
236
446
71
560
390
530
191
390
-23
404
91
665
841
699
411
-329
391
-280
566
45
466
901
807
780
840
331
471
600
242
-16
456
725
656
806
465
1136
162
390
425
701
411
675
152
-269
464
60
911
-4
710
248
869
425
597
499
265
431
679
805
409
949
255
157
493
801
585
-70
-231
470
200
59
-435
-60
689
-35
340
119
167
285
-687
1198
518
-730
506
760
676
-680
951
25
-164
120
696
766
582
857
-510
54
420
336
630
261
-60
446
-10
-4
40
166
71
271
487
-288
693
191
695
236
-589
1085
-1159
211
156
830
211
477
379
446
-518
666
-369
410
186
-39
445
-129
351
-29
5.
. 851
172
543
481
-47-
TABLE 10
FLUID BALANCE SUMMARY
(ml/24 hrs)
Subject
D a y o f Study 1 - 2 3 4
R 1
R 2
R 3
R 4
R 5
R 6
R 7
R 8
R 9
R 10
R 11
R 12
R 13
R 14
B1 1
B1 2
B1 3
B' 4
B' 5
B1 6
B' 7
B' 8
B1 9
B'10
B'll
B'12
B'13
B'14
B'15
1109
645
1017
834
1235
841
858
234
1396
868
340
1190
995
559
685
780
-71
678
1283
661
613
613
719
1713
1616
-420
-379
155
536
30
466
876
720
515
236
380
-132
1125
846
145
1086
-20
221
265
126
326
325
575
.J96
595
388
515
841
981
375
-129
-274
925
-279
827
786
405
231
521
-424
280
961
1051
235
391
-14
275
451
763
670
75
816
-9
706
725
205
544
398
515
876
848
975
376
258
1325
1031
398
-431
133
-447
1149
688
723
174
428
303
-91
1828
213
107
637
506
905
676
55
296
80
336
755
946
335
-263
484
414
-1683
407
811
280
186
-260
11
155
-674
-185
331
235
12
-989
669
-518
269
80
426
391
565
221
211
61
290
301
661
6
370
761
712
-306
-165
-39
-89
390
-599
861
166
345
-19
201
511
465
796
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TABLE 11
FLUID BALANCE SUMMARY
(ml/24 hrs)
Subject A 1-12
Day of Study
B 1-14 R 1-12 B1 1-12
1
2
3
4
5
6
Mean
S.E.(95%)
775
752
332
318
566
435
530
±211.8
506
149
373
151
224
182
264
±151.9
853
683
395
441
434
472
546
±190.5
646
389
470
-32
247
121
307
±257.6
P Values
B vs A <0.05
R vs B <0.025
B1 vs R <0.05
R vs A <0.7
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TABLE 12
URINE CREATININE
(mgm/24 hrs)
' of Study
A 1-7
A 8-13
A 14
B 1-7
B 8-14
B 15
R 1
R 2-7
R 8-12
R 13
R 14
B'l-7
B'8-14
B'15
R'l
R'2-7
Subject
1
1770
1864
1789
, 1833
1554
1808
1915
1808
1917
1788
1777
1800
1807
1773
1829
1860
2
2066
2179
2253
2316
2613
2267
1647
2337
2384
2326
1875
- 2276
2317
2266
2332
2247
3
2355
2338
2345
2376
2409
2446
2501
2360
2283
2232
2512
2374
2346
2326
2483
2362
4
2037
1952
2047
2097
2113
2260
18.95
1953
1930
1878
2071
2079
2081
2018
1945
1943
5
1943
1971
1961
1946
1950
1965
1977
1986
1961
1959
1895
1901
1938
1997
2357
2013
6
1923
1922
2002
1965
2011
1788
1915
1987
2054
1918
1796
2039
2053
1974
2062
1968
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TABLE 13
SERUM CHEMISTRIES
Subject Day of Study Sodium Potassium
meq/L meq/L
A 3 138 4.0
A 9 138 4.0
B 2 139 4.1
B 13 142 4.6
1
 R 9 140 4.0
B1 2 140 4.5
B'14 140 4.3
R'12 140 4.0
A 3 1 3 8 3 . 7
A 9 138 3.8
B 2 138 4.0
„ B 13 139 3.7
R 9 138 3.9
B1 2 138 4.0
B'14 137 " 3.8
R'12 140 4.3
A 3 137 4.4
A 9 138 4.6
B 2 136 4.8
3 B 14 138 4.8
R 9 137 4.6
B1 2 137 4.8
B'14 136 4.9
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TABLE 13
SERUM CHEMISTRIES
Subject Day of Study Sodium Potassium
meq/L meq/L
A3 138 4.9
A 9 139 4.2
B 2 139 4.8
4 B 14 140 5.0
R 9 140 4.7
B' 2 140 5.2
B'14 138 4.2
A 3 140 4.0
A 9 141 3.9
B 2 141 4.4
5 B 14 140 4.3
R 9 143 4.2
B1 2 143 4.3
B'14 141 " 4.4
R'12 140 4.0
A 3 139 3.8
A 9 139 3.9
B 2 139 3.8
B 14 140 3.9
b
 R 9 142 3.8
B' 2 140 3.9
B'14 141 4.2
R'12 142 4.5
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TABLE 14
BODY FLUID COMPARTMENTS
Red
Plasma Cell Extracellular Total Body
Subject Day of Study Volume Mass Fluid Volume Water Weight
(ml) (ml) (L) (L) (kg)
A 3 3136 1917 14.75 41.00 65.11
A 9 2904 14.13 39.91 64.48
B 2 2720 13.70 39.35 63.26
1 B 14 2603 2018 13.84 38.96 63.06
R 9 3255 1926 15.10 39.32 63.49
B1 2 2931 1826 38.59 63.54
B'14 2636 1838 14.45 37.68 63.08
R'12 3234 1924 15.38 41*36 64.78
A 3 3474 2249 19.07 50.56 98.23
A 9 3484 2215 19.04 49.23 98.43
B 2 3471 2051 19.17 49.91 98.47
B 14 3283 2204 18.04 48.73 97.38
2
 R 9 3738 2084 19.75 49.41 97.34
B' 2 3384 2105 97.23
B'14 3230 2096 18.62 48.56 96.96
R'12 3644 2099 19.40 51.43 97.05
A 3 3375 2028 20.00 52.06 79.96
A 9 3181 1984 20.20 . 52.04 79.48
B 2 4078 1990 20.08 52.74 80.38
B 14 3252 1976 19.12 50,32 79.57
3
 R 9 3384 1831 20.56 51.36 79.37
B' 2 3332 1870 20.19 50.05 79.26
B'14 3198 1910 19.65 49.87 79.46
R'13 3437 1786 21.25 52.17 80.37
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TABLE 14
BODY FLUID COMPARTMENTS
Red
Plasma Cell Extracellular Total Body
Subject Day of Study Volume Mass Fluid Volume Water . Weight
(ml) (ml) (L) (L) (kg)
A 3 3543 2024 17.57 46.53 72.42
A 9 3763 1994 17.52 47.99 72.77
B 2 3306 1946 16.50 46.74 71.43
, B 14 3465 1922 16.34 46.24 71.45
R 9 3537 1782 17.08 47.28 71.23
B1 2 3407 1812 16.47 45.20 70.15
B'14 3392 1743 16.47 45.71 70.19
R'13 3914 1670 18.41 46.38 71.96
*
A 3 3249 1892 15.40 44.01 69.54
A 9 3297 1844 15.67 -. 42.44 68.82
B 2 2857 1794 14.18 43.44 68.03
B 14 2880 1726 14.56 42.02 68.00
R 9 3585 1705 15.16 45.50 67.68
B' 2 3184 1738 15.19 42.27 68.00
B'14 2768 1670 14.98 41.95 67.71
R'12 3071 1695 14.65 41.94 68.10
A 3 3597 1945 16.80 46.66 72.52
A 9 3526 1963 17.06 44.06 72.38
B 2 3354 43.30 71.62
B 14 3157 1790 16.53 41.43 71.04
R 9 3362 1722 16.52 44.32 71.26
Bf 2 3225 1710 16.40 45.58 71.81
B'14 2932 1696 16.07 43.69 70.35
R'12 3362 1672 16.26 43.97 70.70
-54-
Day of Study
TABLE 15
BODY FLUID COMPARTMENTS
Group Mean ± S.E.(95%)
Plasma Volume
(ml)
Red Cell Mass
(ml)
P VALUES
Extracellular
Fluid Volume
(L)
Total Body Water
(L)
A 3
A 9
B 2
B 14
R 9
B1 2
B'L2
R'14
3396
±186
3359
±315
3142
±411
3107
±328
3477
±184
3244
±185
3026
±309
3444
±315
2009
±136 '
2000
±167
194-3
±174
1939
±175
1842
±150
1844
±148
1826
±168
1808
±181
17.26
±2.14
17.27
±2.31
16.73
±3.56
16.40
±2.10
17.36
±2.42
17.06
±3.45
16.71
±2.14
17.56
±2.68
46.80
±4.28
45.94
±4.79
45.91
±5.13
44.62
±4.72
46.20
±4.44
44.34
±5.28
44.58
±4.70
46.21
±4.91
B
B
R
B1
B1
R1
2
14
9
2
14
12
vs
vs
vs
vs
vs
vs
A*
A*
A*
R 9
R 9
R 9
<0
<0
<0
<0
<0
<0
.07
.01
.40
.02
.01
.80
<0
<0
<0
<0
<0
<0
.10
.20
.01
.95
.60
.20
<0.10
<oeooi
<0.80
<0.20
<0.005
<0.60
<0
<0
<0
<0
<0
<0
.40
.02
.80
.20
.02
.995
A = A 3 + A 9
2
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TABLE 16
HEMATOCRITS
Subject
Study Day
A 3
A 9
B 2
B 14
R 9
B1 2
B'14
R'12
1
46.6
46.4
47.3
50.4
43.9
46.9
47.4
44,0
2
46.5
46.0
45.1
- 49.5
43.4
44.3
45.6
44.1
3
46.3
45.8
46.1
47.2
44.5
44.6
45.3
41.2
4
44.0
41.9
44.5
43.8
40.7
42.5
41.2
35.7
5
43.9
43.1
45.5
44.6
42,5
44.2
44.2
43.6
6
42.3
42.7
43.2
43.3
40.8
42.0
43.4
40.2
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Subject
TABLE 21
AVERAGE HEART RATE+ DURING LBNP
(Beats/min)
LBNP Magnitude
Day of Study Rest -30mmHg -40mmHg -50mmHg
A 13
B 15
R 13
B'15
R'14
A 13
B 15
R 13
B'15
R'14
A 13
B 15
R 13
B'15
R'14
A 13
B 15
R 13
B'15
R'14
49
57
50
51
55
45
51
54
52
50
48
52
48
49
52
47
48
63
54
56
52
62
60
53
49
62
74
60
68
60
51
60
48
64
53
53
66
72
81
74
54
73
76
58
50
70
94
68
80
65
64
76
58-
80
56
63
84
86
108"
86
69
94
79
80
56
85
109
81
99
80
68
92
78
95
74
96
101
Syncope.
Nausea, pallor, hypotension.
Calculated as the average of the heart rates at each
minute during each level of LBNP.
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Subject
TABLE 22
MAXIMUM HEART RATE DURING LBNP
(Beats/min)
LBNP Magnitude
Day of Study Rest -30mmHg -40mmHg
A 13
B 15
R 13
B'15
R'14
49
57
50
51
55
54
66
64
58
53
60
83
80
61
54
-50mmHg
80
105
84
101
58
A 13
B 15
R 13
B'15
R'14
45
51
54
52
50
66
78
65
72
71
79
98
69
85
76
94
115
86
103
86
A 13
B 15
R 13
B'15
R'14
A 13
B 15
R 13
B'15
R'14
48
52
48
49
52
47
48
63
54
56
55
63
50
67
63
58
70
78
87
90
72
80
73
85
64
69
88
96
110'
95
,**
72
99
93
108
82
84
100*
101
110
Syncope.
fr
Nausea, pallor, hypotension.
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Table 23
Maximum Heart Rate During LBNP
Group Means ±S.E.(9570)
(beats/minute)
LBNP Magnitude
Day of Study Rest -SOmmHg -40mmHg -SOramHg
A 13
B 15
R 13
B'15
R'14
B vs A
R vs B
B1 vs R
R' vs B1
R vs A
R' vs R
47
±2
52
±5
54
±11
52
±3
53
±4
<0
<0
<0
<0
<0
<0
.7
.9
.3
.4
.05
.8
.5
.3
.2
.9
58
±8.6
69
±10
64
±18
71
±19
69
±25
P Values
<0.005
<0,4
<0.3
<0.4
<0.4
<0.5
70
±13
87
±13
80
±19
85
±32
72
±28
<0.02
<0.4
<0.6
<0.05
<0.4
<0.4
82
±15
105
±12
91
±12
104
±9
84
±34
<0.005
<0.2
<0,005
<0.10
<0.3
<0.5
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TABLE 27
RESPONSE TO EXERCISE: OXYGEN CONSUMPTION
(ml/min)
Subject Day of Study Baseline SOW 75W 100W 125W 150W 175W
A 13 264 850 * *
B 15 248 * 1168 1505
1
 R 13 212 940 1234 1541
B'15 250 866 1177 1477
A 13 290 947 1271 1628
B 15 280 953 1272 1662
R 13 316 954 1272 1627
B'15 297 954 1156 1670
A 13 178 950 1180 1571
B 15 194 882 1134 1464
R 13 184 * 1168 '*
B'15 240 894 1103 1234 2250
R'14 226 931 1261 1595 2370
A 13 192 1006 1320 1714
B 15 190 920 1247 1557
R 13 188 862 1297 1577
B'15 241 902 1220 1551 1989
R'14 253 949 1175 1614 2396
A 13 144 955 1203 1604 2600
B 15 197 875 1103 1561 2271
R 13 219 884 1279 1844 2562
B'15 217 761 1220 1698 2197
R'14 256 853 1251 1604 2869
A 13 218 938 1256 1592 2507
B 15 200 921 1189 1654 1991
R 13 234 1003 1205 1777 2654
B'15 186 864 1231 1577 2023
R'14 218 901 1298 1763 2681
*
Technical inaccuracies in gas collection.
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Subject
1
2
3
4
5
6
A 13
*
3011
2184
2829
2708
2601
B 15
2268
2679
2185
2156
2455
2256
Mean
TABLE 28
DERIVED MAXIMAL OXYGEN UPTAKE
(ml/rain)
Day of Study
R 13 B1 15
2677 2146
2947 2788
* 2315
2491 2104
2742 2265
2854 2161
2667 2333 2742 2296
R1 14
2617
2564
2999
2612
2698
S.E.(95%) ±384.7 ±208.8 ±216.5 ±265.9 ±321.6
*
Data inadequate for accurate calculation.
P Values
A 13 vs B 15
B 15 vs R 13
R 13 vs B'15
B'15 vs R'14
A 13 vs R 13
R 13 vs R'14
<0.05
<0.005
<0.01
<0.02
<0.9
<0.9
eo
atC
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Table 32
Maximum Heart Rate During Centrifuge Studies
Group Means ±S.E.(95%)
(beats/minute)
Day of Study Rest +2.1 G +3.2 G +3.8 G
A 14
BR-
BR+
R 14
R14 vs A14
BR- vs A 14
BR- vs R14
BR+ vs A 14
BR+ vs R14
BR+ vs BR-
53
±7.9
59
±7.1
58
±3.2
56
±9.3
<0.4
<0.005
<0.4
<0.3
<0.6
<0.9
112
±22
143
±22
124
±36
113
±17
P Values
<0.95
<0.001
<0.005
<0.2
<0.4
<0.05
142
±27
161
±21
139
±12
137
±16
<0.3
<0.005
<0.005
<0.6
<0.7
<0.05
150
±28
169
±14
147
±26
152
±23
<0.95
<0.10
<0.05
<0.7
<0.7
<0.05
+ With G-suit.
- Without G-suit.
SODIUM BALANCE (meq./24 hrs.)
GROUP MEANS AND STANDARD ERRORS
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o
z
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RECOVERY
14 " 7
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15 7
RECOVERY
Figure I
Sodium Balance. Group means on specific days or in
specific periods of the study.
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DERIVED MAXIMUM OXYGEN UPTAKE (ml./min.)
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Figure 2
Sodium Balance, Potassium Balance, Fluid Balance and
Derived Maximal Oxygen Uptake. Group means and standard
errors.
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0 7 14
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Figure 3
Body Fluid Compartments. Group means and standard errors
on specific study days.
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• RECOVERY PERIOD
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20 0
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10
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20 O 10 20
Figure 4
4. Heart Rate Responses to 70° Tilt (+1 GZ). Subjects 1
and 2.
S -so
OAMBULATORY CONTROL
oeCDREST I
•RECOVERY I
. etOREST 2
•RECOVERY 2
Figure 5a
Heart Rate Responses to LBNP,
° AMBULATORY CONTROL
OBEDREST I
•RECOVERY I
•BEOREST 2
* RECOVERY 2
MINUTES
Figure 5b
Heart Rate Responses to LBPN. Subects 3» 4, 5,, and 6.
1601
600
o AMBULATORY CONTROL
° BEOREST WITHOUT G-SUIT
Figure 6
Heart Rate Responses to +2.1 GZ. Bedrest without G-suit
and ambulatory control runs in all subjects.
IZOn
40
600
• RECOVERY PERIOD
• BEOREST WITH 6-SUIT
Figure 7
Heart Rate Responses to +2.1 G . Bedrest with G-suit
and recovery period runs in all subjects.
600
o AMBULATORY CONTROL
• RECOVERY PERIOD
Figure 8
Heart Rate Responses to +2.1 G . Ambulatory control and
recovery period runs in all subjects.
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SECONDS
Figure 9a
Heart Rate Responses to +3.2GZ, Subects 1 and 2,
0 60 120 ISO 240 0 60 120 ISO 240 0 6O 120 180 240
0 60 120 ISO 240 0 60 120 ISO 240 0 SO 120 ISO 240
o AMBULATORY CONTROL SECONDS
DBEOHEST WITHOUT G-SUIT
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Figure 9b
Heart Rate Responses to +3,2GZ. Subjects 3 and 4,
0 60 120 ISO 240 0 60 120 180 240 0 60 120 ISO 240
0 60 120 ISO 240 0 60 120 ISO 24O 0 60 120 ISO 240
o AMBULATORY CONTROL
oBEOREST WITHOUT G-SUIT
• RECOVERY PERIOD
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Figure 9c
Heart Rate Responses to +3.2GZ. Subjects 5 and 6.
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Figure lOa
Heart Rate Responses to +3.8 Gz. Subjects 1 and 2,
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Figure lOb
Heart Rate Responses to +3.8 Gz. Subjects 3 and 4,
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Figure lOc
Heart Rate Responses to +3.8 Gz. Subjects 5 and 6,
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Figure 11
Maximtun Heart Rates During Centrifugation. Group means
and standard errors.
